Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
Colesevelam’s glucose-lowering mechanism of action is not completely understood. Clinical trials of colesevelam suggest that its mechanism, and often adverse effects, differ from those of other oral antidiabetes drugs. Colesevelam does not affect insulin sensitivity (unlike thiazolidinediones), insu...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Libertas Academica
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864737/ |